TB Alliance is a not-for-profit organisation and PDP dedicated to the discovery, development and delivery of better, faster-acting and affordable tuberculosis drugs. The TB Alliance is uniquely positioned to leverage a global network of public and private partners to advance TB drug development and access. Since its inception in 2000, TB Alliance has led the global search for and development of new TB regimens, catalysing the field and convening cross-sector partnerships to forge the progress that is urgently needed for better TB treatments. Additionally, TB Alliance’s mission includes an explicit commitment to our “AAA Mandate”—that all new products will be adopted, available, and affordable to those with TB.